According to the US Food and Drugs Administration (US-FDA) reviewers, Merck’s cholesterol lowering drug called Vytorin is effective lowering the rate of heart attack or other cardiovascular problems among patients with kidney disease. Merck’s blockbuster drug, according to the FDA review panel, is a mix of Zetia, a new type of cholesterol fighting drug and Related posts: FDA

Approved New pill Finally, FDA had approved one pill named Ella which is… Enrollment of Avandia to End The United States Food and Drug Administration has passed a… Risk for Diabetes in Patients with Kidney Stones Having diabetes can surely predispose a person to a lot…

Read more from the original source:
FDA Finds Vytorin